期刊文献+

肝细胞癌组织和癌周组织中p53基因密码子249突变的比较研究 被引量:1

Comparison of codon 249 mutations of p53 gene in cancerous tissues with that in pericancerous tissues of HCCs
下载PDF
导出
摘要 目的:本研究通过比较研究HCC 癌组织和癌周组织中p53 基因密码子249 特征性突变来进一步阐明该基因在HCC 发生机制中的意义。方法:收集9 份癌组织中经单链构型多态性分析研究证实存在密码子249 突变的HCC 标本和11 例无此突变的HCC 标本,采用等位基因特异性PCR(AS- PCR) 方法比较研究癌组织和癌周组织中密码子249 突变情况。结果:20 例HCC 中,癌周组织中密码子249 特征性突变检出率为70 % 。9 例SSCP 阳性者的癌周组织中的特征性突变检出率达100 % 。11 例阴性患者的癌组织和癌周组织也能检出一定水平的突变。结论:p53基因密码子249 突变在非癌肝组织中广泛存在。癌组织中密码了249 特征性突变可能发生在肿瘤形成之前。 Objective:To analyze codon 249 mutation of p53 gene in cancerous tissue and pericancerous tissue of HCC comparatively,and study the significance of p53 gene in hepatocarcinogenesis.Methods:Codon 249 mutations were detected using allele specific PCR in cancerous and pericancerous tissues of 9 codon 249 mutation positive cases and 11 negative cases detected by single stranded conformational polymorphism (SSCP) analysis in former research.Results:The detective rate of codon 249 mutation in pericancerous tissues was 70%(14/20).That in 9 cases of SSCP positive HCCs was 100%(9/9).Codon 249 mutations were also detected in cancerous and pericancerous tissues of 11 SSCP negative HCCs.Conclusions:Codon 249 mutations of p53 gene were very popular in non neoplastic tissues.Those mutations in cancerous tissues might take place in the stage before the formation of tumor.
出处 《癌症》 SCIE CAS CSCD 北大核心 1999年第5期526-527,534,共3页 Chinese Journal of Cancer
基金 美国中华医学基金会(CMB) 部分资助!(Grant No93 - 582)
关键词 P53基因 肝细胞癌 密码子249 基因突变 Hepatoma p53 gene Mutation
  • 相关文献

参考文献2

  • 1彭晓谋,中山医科大学学报,1997年,18卷,245页
  • 2Hsu I C,Nature,1991年,350卷,427页

同被引文献10

  • 1覃文新,潘勇,姚根富,万大方,顾健人.非放射性PCR-LIS-SSCP技术快速分析肝癌患者p53基因249位密码子的突变[J].肿瘤,2004,24(4):318-321. 被引量:4
  • 2Vousden K H.Activation of the p53 tumor suppressor protein[J].Biochim Biophya Acta,2002,1602:47-59.
  • 3DongDong L,XiRan Z.Plasma 249Ser p53 mutation in patients with hepatocellular carcinoma residing in a high risk area[J].J Cell Mol Med,2003,7 (1):89.
  • 4Gregory D Kirk,Olufunmilayo A Lesil,Maimuna Mendy.249ser TP53 mutation in plasma DNA,hepatitis B viral infection,and risk of hepatocellular carcinoma[J].Oncogene,2005,24,5858-5867.
  • 5GERALD C KIMBI,MICHAEL C KEW,MIMIC YU.249ser p53 mutation in the serum of black southern African patients with hepatocellular carcinoma[J].Journal of Gastroenterology and Hepatology,2005,20; 1185 - 1190.
  • 6Wang X W,Forrester K,Yeh H,et al.Hepatitis B virus x protein inhibits p53 sequence specific DNA binding,transcriptional activity,and association with transcription factor ERCC3[J].Proc Natl Acad Sci USA,1994,91:2230.
  • 7Kirby GM,Chemin I,Montesano R,et al.Induction of specific cytochrome P450s involved in aflatoxin B1 metabolism in hepatitis B virus transgenic mice[J].Mol Carcinog,1994,11 (2):74-80.
  • 8Kaplanski C,Chisari F V,Wild C P.Minisatellite rearrangements are increased in liver tumors induced by aflatoxin B1 treatment of hepatitis B virus transgenic mice,but not in spontaneously arising tumors[J].Carcinogenesis,1997,18 (4):633-639.
  • 9Levine A J,Momand J,F inlay C A.The P53 tumor suppressor gene[J].Nature,1991,351:453.
  • 10Hollstein M,Sidransdy D,Vogelstoin B,Harris C C.p53 mutation in human cancers[J].Science,1991,253(5015),49 - 53.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部